231 related articles for article (PubMed ID: 32415710)
21. Vancomycin dosing in critically ill trauma patients: The VANCTIC Study.
Villanueva RD; Talledo O; Neely S; White B; Celii A; Cross A; Kennedy R
J Trauma Acute Care Surg; 2019 Nov; 87(5):1164-1171. PubMed ID: 31464871
[TBL] [Abstract][Full Text] [Related]
22. Subgroup identification-based model selection to improve the predictive performance of individualized dosing.
Soeorg H; Kalamees R; Lutsar I; Metsvaht T
J Pharmacokinet Pharmacodyn; 2024 Jun; 51(3):253-263. PubMed ID: 38400995
[TBL] [Abstract][Full Text] [Related]
23. Prospective evaluation of vancomycin pharmacokinetics in a heterogeneous critically ill population.
Turner RB; Kojiro K; Won R; Chang E; Chan D; Elbarbry F
Diagn Microbiol Infect Dis; 2018 Dec; 92(4):346-351. PubMed ID: 30025969
[TBL] [Abstract][Full Text] [Related]
24. The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens*.
Jamal JA; Udy AA; Lipman J; Roberts JA
Crit Care Med; 2014 Jul; 42(7):1640-50. PubMed ID: 24674926
[TBL] [Abstract][Full Text] [Related]
25. Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.
Roberts DM; Roberts JA; Roberts MS; Liu X; Nair P; Cole L; Lipman J; Bellomo R;
Crit Care Med; 2012 May; 40(5):1523-8. PubMed ID: 22511133
[TBL] [Abstract][Full Text] [Related]
26. Importance of Decision Support Implementation in Emergency Department Vancomycin Dosing.
Faine B; Mohr N; Harland KK; Rolfes K; Porter B; Fuller BM
West J Emerg Med; 2015 Jul; 16(4):557-64. PubMed ID: 26265968
[TBL] [Abstract][Full Text] [Related]
27. External Validation of Model-Based Dosing Guidelines for Vancomycin, Gentamicin, and Tobramycin in Critically Ill Neonates and Children: A Pragmatic Two-Center Study.
Hartman SJF; Orriëns LB; Zwaag SM; Poel T; de Hoop M; de Wildt SN
Paediatr Drugs; 2020 Aug; 22(4):433-444. PubMed ID: 32507958
[TBL] [Abstract][Full Text] [Related]
28. Monitoring of a single post-infusion blood sample to estimate the actual peak and trough concentration of tobramycin in critically ill patients.
Reimann IR; Meier-Hellmann A; Traut T; Reinhart K; Hoffmann A
Exp Toxicol Pathol; 2003 Jun; 54(5-6):493-8. PubMed ID: 12877363
[TBL] [Abstract][Full Text] [Related]
29. Efficiency of dosing software using Bayesian forecasting in achieving target antibiotic exposures in critically ill patients, a prospective cohort study.
Chai MG; Roberts JA; Kelly CF; Ungerer JPJ; McWhinney BC; Lipman J; Farkas A; Cotta MO
Anaesth Crit Care Pain Med; 2023 Dec; 42(6):101296. PubMed ID: 37579945
[TBL] [Abstract][Full Text] [Related]
30. Population pharmacokinetic model of Vancomycin based on therapeutic drug monitoring data in critically ill septic patients.
Kovacevic T; Miljkovic B; Kovacevic P; Dragic S; Momcicevic D; Avram S; Jovanovic M; Vucicevic K
J Crit Care; 2020 Feb; 55():116-121. PubMed ID: 31715528
[TBL] [Abstract][Full Text] [Related]
31. Vancomycin Pharmacokinetics in Obese Patients with Sepsis or Septic Shock.
Masich AM; Kalaria SN; Gonzales JP; Heil EL; Tata AL; Claeys KC; Patel D; Gopalakrishnan M
Pharmacotherapy; 2020 Mar; 40(3):211-220. PubMed ID: 31957057
[TBL] [Abstract][Full Text] [Related]
32. Continuous Learning in Model-Informed Precision Dosing: A Case Study in Pediatric Dosing of Vancomycin.
Hughes JH; Tong DMH; Lucas SS; Faldasz JD; Goswami S; Keizer RJ
Clin Pharmacol Ther; 2021 Jan; 109(1):233-242. PubMed ID: 33068298
[TBL] [Abstract][Full Text] [Related]
33. Individualized Pharmacokinetic Dosing of Vancomycin Reduces Time to Therapeutic Trough Concentrations in Critically Ill Patients.
Truong J; Smith SR; Veillette JJ; Forland SC
J Clin Pharmacol; 2018 Sep; 58(9):1123-1130. PubMed ID: 29957824
[TBL] [Abstract][Full Text] [Related]
34. Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients.
Mena M; Garcia JC; Bustos RH
Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830212
[TBL] [Abstract][Full Text] [Related]
35. Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients.
Radke C; Horn D; Lanckohr C; Ellger B; Meyer M; Eissing T; Hempel G
Clin Pharmacokinet; 2017 Jul; 56(7):759-779. PubMed ID: 28039606
[TBL] [Abstract][Full Text] [Related]
36. A Model Averaging/Selection Approach Improves the Predictive Performance of Model-Informed Precision Dosing: Vancomycin as a Case Study.
Uster DW; Stocker SL; Carland JE; Brett J; Marriott DJE; Day RO; Wicha SG
Clin Pharmacol Ther; 2021 Jan; 109(1):175-183. PubMed ID: 32996120
[TBL] [Abstract][Full Text] [Related]
37. Vancomycin is commonly under-dosed in critically ill children and neonates.
Sosnin N; Curtis N; Cranswick N; Chiletti R; Gwee A
Br J Clin Pharmacol; 2019 Nov; 85(11):2591-2598. PubMed ID: 31378957
[TBL] [Abstract][Full Text] [Related]
38. Individualizing vancomycin dosing regimens: an evaluation of two pharmacokinetic dosing programs in critically ill patients.
Fernández de Gatta MM; Fruns I; Domínguez-Gil A
Pharmacotherapy; 1994; 14(2):196-201. PubMed ID: 8197039
[TBL] [Abstract][Full Text] [Related]
39. Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy.
Economou CJP; Kielstein JT; Czock D; Xie J; Field J; Richards B; Tallott M; Visser A; Koenig C; Hafer C; Schmidt JJ; Lipman J; Roberts JA
Int J Antimicrob Agents; 2018 Aug; 52(2):151-157. PubMed ID: 29526606
[TBL] [Abstract][Full Text] [Related]
40. External Evaluation of Population Pharmacokinetic Models of Vancomycin in Large Cohorts of Intensive Care Unit Patients.
Guo T; van Hest RM; Roggeveen LF; Fleuren LM; Thoral PJ; Bosman RJ; van der Voort PHJ; Girbes ARJ; Mathot RAA; Elbers PWG
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30833424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
